Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the common iliac arteries

European Journal of Vascular and Endovascular Surgery

Volumn 31, Issue 3, 2006, Pages 244-250

  Laxdal, Elin ^a,b   Wirsching, J ^a   Pedersen, G ^a   Bertz, A ^a   Amundsen, S R ^a   Dregelid, E ^a   Jonung, T ^b   Nyheim, T ^a   Aune, S ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Common iliac arteries; D Dimer; Fibrinogen; Homocysteine; PTA; Reocclusion; Restenosis; Survival analysis

Indexed keywords

ACTIVATED PROTEIN C; D DIMER; FIBRINOGEN; HOMOCYSTEINE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOGRAPHY; ARTERY DISSECTION; ARTERY PERFORATION; ARTERY RECONSTRUCTION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; EMBOLISM; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GRAFT PATENCY; HEMATOMA; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; ILIAC ARTERY OBSTRUCTION; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGICAL RISK; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; GRAFT OCCLUSION, VASCULAR; HEMOSTASIS; HOMOCYSTEINE; HUMANS; ILIAC ARTERY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 33144458241     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.06.032     Document Type: Article

References (49)

1. J.L. Bosch M.G. Hunink Meta-analysis of the results of percutanous transluminal angioplasty and stent placement for aortoiliac occlusive disease Radiology 204 1997 87-96
2. J.P. Becquemin E. Allaire P. Qvarfordt P. Desgranges H.M. Kolbeiter Surgical transluminal iliac angioplasty with selective stenting: long-term results assessed by means of duplex scanning J Vasc Surg 29 1999 422-429
3. S. Glacov Intimal hyperplasia, vascular modelling and restenosis problem Circulation 89 1994 2888-2891
4. C.C. Haudenschild Pathobiology of restenosis after angioplasty Am J Med 94 Suppl 4A 1993 40s-44s
5. H. van Goor A.H. Boontje Results of vascular reconstructions for atherosclerotic arterial occlusive disease of the lower limbs in young adults Eur J Vasc Endovasc Surg 10 3 1995 323-326
6. S. Aune E. Laxdal Above-knee prosthetic femoropopliteal bypass for intermittent claudication. Results of the initial and secondary procedures Eur J Vasc Endovasc Surg 19 5 2000 476-480
7. E. Laxdal G.L. Jenssen G. Pedersen S. Aune Subintimal angioplasty as a treatment of femoropopliteal artery occlusions Eur J Vasc Endovasc Surg 25 6 2003 578-582
8. D.H. Olojugba M.J. McCarthy A. Reid K. Varty A.R. Naylor P.R. Bell et. al. Infrainguinal revascularisation in the era of vein-graft surveillance-do clinical factors influence long-term outcome? Eur J Vasc Endovasc Surg 17 2 1999 121-128
9. E. Laxdal G.E. Eide J. Wirsching G.L. Jenssen T. Jonung G. Pedersen et. al. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery Eur J Vasc Endovasc Surg 28 4 2004 410-417
10. M. Schillinger M. Exner W. Mlekusch H. Rumpold R. Ahmadi S. Sabethi et. al. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries Thromb Haemost 87 2002 959-965
11. E.S.K. Sampram B. Lindblad B. Dahlbäck Activated protein C resistance in peripheral vascular disease J Vasc Surg 28 1998 624-629
12. L.M. Taylor R.D. DeFrang E.J. Harris J.M. Porter The association of elevated plasma homocysteine with progression of symptomatic pheripheral artery disease J Vasc Surg 13 1991 128-136
13. H. Lange H. Suryapranata G. De Luca C. Borner J. Dille K. Kallmayer et. al. Folate therapy and in-stent restenosis after coronary stenting N Engl J Med 350 26 2004 2673-2681
14. G. Schnyder M. Roffi Y. Flammer R. Pin O.M. Hess Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty Eur Heart J 23 9 2002 726-733
15. G.J. de Borst M.J.D. Tangelder A. Algra J.A. Lawson J.D. Banga B.C. Eikelboom et. al. The influence of hyperhomocysteinemia on graft patency after infrainquinal bypass surgery in the Dutch BOA Study J Vasc Surg 36 2002 336-340
16. D.K. Beattie M. Sian R.M. Greenhalg A.H. Davies Influence of systemic factors on pre-existing intimal hyperplasia and their effect on the outcome of infraiguinal arterial re-construction with vein Br J Surg 86 1999 1441-1447
17. C. Irvine Y.G. Wilson I.C. Currie C. McGrath J. Scott A. Day et. al. Hyper-homocysteinemia is a risk factor for vein graft stenosis Eur J Vasc Endovasc Surg 12 1996 304-309
18. I.C. Currie Y.G. Wilson J. Scott A. Day D. Stansbie R.N. Baird et. al. Homocysteine: An independent risk factor for the failure of vascular intervention Br J Surg 83 1996 1238-1241
19. E. Laxdal G.E. Eide S.R. Amundsen E.B. Dregelid G. Pedersen T. Jonung et. al. Homocysteine levels, haemostatic risk factors and restenosis after carotid thrombendarterectomy Eur J Vasc Endovasc Surg 28 2004 323-328
20. R.H. Samson Z. Yungst D.P. Showalter Homocysteine, a risk factor for carotid atherosclerosis, is not a risk factor for early recurrent carotid stenosis following carotid endarterectomy Vasc Endovascular Surg 38 4 2004 345-348
21. T. Kovacevic B. Van Der Loo B.R. Amann-Vesti V. Rousson R. Koppensteiner Plasma homocysteine and restenosis after femoropopliteal angioplasty Endovasc Ther 11 3 2004 302-309
22. D.A. Tsakiris M. Tschøpl K. Jäger W.E. Haefeli F. Wolf G.A. Marbet Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease Atherosclerosis 142 1999 193-200
23. K. Osterberg E. Mattsson Intimal hyperplasia in mouse vein grafts is regulated by flow J Vasc Res 42 1 2005 13-20 [Epub 2004 Dec 17]
24. C.M. Fernandez D.R. Goldman Z. Jiang C.K. Ozaki R. Tran-Son-Tay S.A. Berceli Impact of Shear stress on early vein graft remodeling: A biomechanical analysis Ann Biomed Eng 32 11 2004 1484-1493
25. M. Schillinger M. Exner W. Mlekusch M. Haumer R. Ahmadi H. Rumpold et. al. Inflammatory response to stent implantation: Differences in femoropopliteal, iliac and carotid arteries Radiology 224 2 2002 529-535
26. T. Royo J. Martinez-Gonzàlez G. Vilahur L. Badimon Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells Atherosclerosis 167 2003 55-63
27. E. Tetteroo C. Haaring Y. van der Graaf J.P. van Schaik A.D. van Engelen W.P. Mali Intrarterial pressure gradients after randomized angioplasty or stenting of iliac artery lesions. Dutch Iliac Stent Trial Study Group Cardiovasc Intervent Radiol 19 1996 411-417
28. Second European Consensus Document on chronic critical leg ischaemia. Eur J Vasc Surg 1992;6:1-32.
29. C.T. Dotter M.P. Judkins Transluminal treatment of atherosclerotic obstructions. Description of a new technique and a preliminary report of its application Circulation 30 1964 654
30. M. Hennerici D. Neuerburger-Heusler Vascular diagnosis with ultrasound 1998 Thieme Medical Publishers Stuttgart, New York
31. A. Greiner A. Dessl P. Klein-Weigel B. Neuhauser R. Perkmann P. Waldenberger et. al. Kissing stents for treatment of complex aortoiliac disease Eur J Vasc Endovasc Surg 26 2 2003 161-165
32. M.J. Koelemay D. den Hartog M.H. Prins J.G. Kromhout D.A. Legemate M.J. Jacobs Diagnosis of arterial disease of the lower extremities with duplex ultrasonograhy Br J Surg 83 1996 404-409
33. K.S. McCully Vascular pathology of homocysteinemia: Implications for the pathogenesis of atherosclerosis Am J Patholog 56 1969 111-128
34. H. Refsum O. Nygard G. Kvale P.M. Ueland S.E. Vollset The Hordaland homocysteine study: The opposite tails odds ratios reveal differential effects of gender and intake of vitamin supplements at high and low plasma total homocysteine concentrations J Nutr 126 Suppl 4 1996 1244S-1248S
35. S.E. Vollset H. Refsum A. Tverdal O. Nygard J.E. Nordrehaug G.S. Tell et. al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: The Hordaland Homocysteine Study Am J Clin Nutr 74 1 2001 130-136
36. E.K. Hoogeveen P.J. Kostense C. Jakobs J.A. Rauwerda J.M. Dekker G. Nijpels et. al. Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study J Int Med 247 4 2000 442-448
37. P.M. Ridker M.J. Stampfer N. Rifai Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine lipoprotein (a), and standard cholesterol screening as predictors for pheripheral arterial disease JAMA 285 2001 2481-2485
38. B. Symonides A. Januszewicz O. Rowinski M. Januszewicz J. Chodakowska H. Berent et. al. Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis J Cardiovasc Risk 6 4 1999 269-272
39. A. Avci A. Boyaci K. Cagli A. Cosgun V. Gokce E. Duru et. al. Influence of haematological parameters before coronary angioplasty on subsequent restenosis Acta Cardiol 59 3 2004 263-268
40. M. Otsuka Y. Hayashi H. Ueda M. Imazu N. Kohno Predictive value of preprocedural fibrinogen concerning coronary stenting Atherosclerosis 164 2 2002 371-378
41. H. Volzke R. Grimm D.M. Robinson B. Wolff C. Schwahn S. Hertwig et. al. Candidate genetic markers and the risk of restenosis after coronary angioplasty Clin Sci (London) 106 1 2004 35-42
42. G. Montalescot A. Ankri E. Vicaut G. Drobinski Y. Grosgogeat D. Thomas Fibrinogen after coronary angioplasty as a risk factor for restenosis Circulation 92 1 1995 31-38
43. J.F. Price N. Mamode F.B. Smith K.R. Woodburn A. Rumley G.D. Lowe et. al. Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty Eur J Vasc Endovasc Surg 14 5 1997 392-398
44. M. Tschopl D.A. Tsakiris G.A. Marbet K.H. Labs K. Jager Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty Arterioscler Thromb Vasc Biol 17 11 1997 3208-3214
45. D.A. Tsakiris M. Tschopl F. Wolf K.H. Labs K.A. Jager G.A. Marbet Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease Blood Coagul Fibrinolysis 11 2 2000 165-173
46. B. van der Loo T. Kovacevic E. Krieger S. Banyai M. Banyai B.R. Amann-Vesti et. al. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): Role of plasma viscosity and low platelet count in predicting restenosis Clin Hemorheol Microcirc 32 2 2005 159-168
47. M. Schillinger M. Haumer G. Schlerka W. Mlekusch M. Exner R. Ahmadi et. al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: The role of inflammation J Endovasc Ther 8 5 2001 477-483
48. M. Schillinger M. Exner W. Mlekusch H. Rumpold R. Ahmadi S. Sabeti et. al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: Association with restenosis Radiology 225 1 2002 21-26
49. D. Prisco E. Antonucci S. Fedi M. Margheri C. Giglioli M. Comeglio et. al. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study Clin Exp Med 1 4 2001 219-224